Authors - Johnson, Marcou, Isaacs & Nix, LLC

Apr 27 2026

Teva v. Lilly: The “Well-Known Genus Used as Part of a Different Invention” Doctrine Gets a Federal Circuit Revival

By: Brent Nix

April 27, 2026

Insights

On April 16, 2026, the Federal Circuit reversed a District of Massachusetts JMOL that had erased a $176.5 million jury […]...

Insights

Oct 27 2025

USPTO Streamlined Claim Set Pilot Program

By: Brent Nix

October 27, 2025

Insights

The USPTO launched a new Streamlined Claim Set Pilot Program on October 27, 2025, offering expedited examination for certain utility...

Insights

Oct 8 2025

USPTO Update – Automated Search Pilot Program

By: Brent Nix

October 8, 2025

General

The USPTO takes another step in the direction of AI-assisted search with a new pilot program. Starting October 20, the […]...

General

Sep 29 2025

UniCure Reports Positive 3-Year Huntington’s Gene Therapy Data: Unique IP Considerations for Complex Gene Therapy Programs

By: Brent Nix

September 29, 2025

Insights

UniCure announced positive 3-year data for their Huntington’s disease gene therapy this week, with the company receiving FDA...

Insights

Feb 28 2025

Navigating AI Patent Protection: Strategic Considerations for Biotech Companies

By: Brent Nix

February 28, 2025

General

As artificial intelligence (AI) continues transforming the biotechnology landscape, protecting AI-related innovations has become...

General

Posts by: F. Brent Nix, J.D., M.Sc.

Teva v. Lilly: The “Well-Known Genus Used as Part of a Different Invention” Doctrine Gets a Federal Circuit Revival

USPTO Streamlined Claim Set Pilot Program

USPTO Update – Automated Search Pilot Program

UniCure Reports Positive 3-Year Huntington’s Gene Therapy Data: Unique IP Considerations for Complex Gene Therapy Programs

Navigating AI Patent Protection: Strategic Considerations for Biotech Companies

Categories

Articles by Attorneys

Articles by Practices

Archives

Related Posts

Posts by: F. Brent Nix, J.D., M.Sc.

Teva v. Lilly: The “Well-Known Genus Used as Part of a Different Invention” Doctrine Gets a Federal Circuit Revival

USPTO Streamlined Claim Set Pilot Program

USPTO Update – Automated Search Pilot Program

UniCure Reports Positive 3-Year Huntington’s Gene Therapy Data: Unique IP Considerations for Complex Gene Therapy Programs

Navigating AI Patent Protection: Strategic Considerations for Biotech Companies

Share

Categories

Articles by Attorneys

Articles by Practices

Archives

Related Posts

subscribe

Subscribe to our newsletter